Fingerprint
Dive into the research topics of 'Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Jai Perumal*, Roumen Balabanov, Ray Su, Roger Chang, Laura Balcer, Steven Galetta, Denise I. Campagnolo, Robin Avila, Lily Lee, Danette Rutledge, Robert J. Fox
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations